AI Visibility Is Now a Pharma Compliance Issue. Here’s the Proof.
Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP […]
Walk into any pharmaceutical compliance team’s weekly meeting and you’ll find the same agenda items from the past decade: OPDP […]
There’s a revealing pattern hidden inside patient search behavior. It’s not the ultra-rare oncology agents or impossible-to-pronounce biologics generating the
Why migraine drugs became weight-loss forums, cholesterol pills turned into food-interaction experiments, and cancer therapies spawned Reddit-scale crowdsourced medicine. There’s
Inside the wonderfully unfiltered world of drug questions people actually ask online Spend enough time around pharmaceutical R&D and you
Pfizer paid $2.3 billion in 2009. GlaxoSmithKline paid $3 billion in 2012. AstraZeneca paid $520 million in 2010. Each of
On September 30, 2004, Merck pulled Vioxx from every pharmacy shelf in the world. The withdrawal took less than 24
There’s a repeating theme across DrugChatter: not “what are the side effects?” but “is this normal—or something I should worry
There’s a quiet sorting mechanism in medicine that has little to do with pharmacology textbooks and everything to do with
If you spend enough time around athletes, weekend warriors, or anyone optimizing “fitness,” you start to notice a recurring theme:
Every so often the public conversation about medicines drifts into a familiar question: why is this one so expensive? But
Chatbots now answer drug questions that once required a detail rep, a pharmacist, or a Medical Information call center. The
AI Agents Now Influence Which Drugs Patients Ask For — Here’s the Pharma Playbook When a patient with newly diagnosed
Sign in or create a free account to read this DrugChatter article